Osteopontin antisense deoxyoligonucleotides inhibit bone resorption by mouse osteoclasts in vitro

Osteopontin (OPN) is an acidic phosphoprotein synthesized by osteoblasts and osteoclastic cells that are localized in the mineralized phase of bone matrix. OPN is thought to bind to the vitronection receptor on the osteoclast membrane and regulates bone resorption by the osteoclast. In this study, we investigated whether or not OPN can relate to osteoclast differentiation and bone resorption in a co‐culture system. When C57Black/6N mouse bone marrow cells suspended on ivory slices coated with collagen were inoculated onto a MC3T3‐G2/PA6 cell layer, colonies containing TRAP(+) mononuclear and multinuclear cells were formed in the presence of 1α, 25‐dihydroxyvitamin D 3 and dexamethasone. At the end of the culture period the number of TRAP(+) osteoclast‐like cells were counted and the resorption pits were evaluated by reflected light microscopy. The mRNA of OPN was detected by in situ hybridization. Osteoclast‐like cells expressed OPN mRNA. The addition of an OPN antisense oligomer(5’AAT CAC TGC CAA TCT CAT 3′) at the start of the co‐culture period decreased the number of TRAP(+) cells present after 7 d (30.3 ± 3.4 vs 56.9 ± 12.4), and the ratio of mononuclear and multinucleated cells was changed (77.6:23.2 vs 60.8:39.3). The total area of pits per ivory slice was also decreased by adding the OPN antisense oligomer(246813 vs 303139 μm2). These results showed that OPN can be an important mechanism for regulating differentiation and bone resorption.